ARTICLE | Politics & Policy
FDA's Sherman leaving as OMP director
December 18, 2013 1:17 AM UTC
Rachel Sherman, director of the Office of Medical Policy (OMP) in FDA's Center for Drug Evaluation and Research (CDER), will retire in January, according to an agency spokesperson. Denise Hinton, director of OMP's Office of Medical Policy Initiatives, will serve as acting OMP director. ...